Apple and its competitors will most likely crush the OTC market.
Presently the OTC market is populated by specific products yet Apple has decided to offer the same or similar features on their existing product. They have in effect commoditised hearing tests and self adjustment.
Apple's competitors will step up with similar features in their devices, they will have no choice but to do it.
I wonder if anyone is looking at NUH to provide that offering and whether Azure/KPMG see the opportunity?
Miller's strategy is dead.
Add to My Watchlist
What is My Watchlist?